Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases

Details for Australian Patent Application No. 2006334856 (hide)

Owner Bayer HealthCare AG

Inventors Hillisch, Alexander; Stoll, Friederike; Schlemmer, Karl-Heinz; Akbaba, Metin; Barfacker, Lars; Klein, Martina; Jeske, Mario; Lampe, Thomas; Karig, Gunter; Schohe-Loop, Rudolf; Stasch, Johannes-Peter; Meininghaus, Mark; Becker, Eva-Maria; Beck, Hartmut; Kast, Raimund; Knorr, Andreas; Schuhmacher, Joachim

Agent Davies Collison Cave

Pub. Number AU-A-2006334856

PCT Pub. Number WO2007/079862

Priority 102005061170.2 21.12.05 DE

Filing date 8 December 2006

Wipo publication date 19 July 2007

International Classifications

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/079862 Priority application(s): WO2007/079862

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft 2007

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006334867-Unmanned aircraft for telecommunicative or scientific purposes

2006334855-Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases